Zymeworks Inc.
ZYME
$25.10
-$0.93-3.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 134.48M | 122.87M | 93.38M | 76.30M | 62.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 134.48M | 122.87M | 93.38M | 76.30M | 62.20M |
| Cost of Revenue | 142.83M | 143.60M | 139.50M | 136.50M | 124.66M |
| Gross Profit | -8.35M | -20.74M | -46.11M | -60.20M | -62.46M |
| SG&A Expenses | 62.27M | 61.97M | 62.70M | 61.51M | 60.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 205.10M | 205.58M | 202.20M | 198.01M | 184.81M |
| Operating Income | -70.61M | -82.71M | -108.81M | -121.70M | -122.61M |
| Income Before Tax | -56.07M | -67.42M | -107.17M | -116.61M | -118.02M |
| Income Tax Expenses | 7.36M | 6.25M | 6.51M | 6.08M | -4.35M |
| Earnings from Continuing Operations | -63.43 | -73.68 | -113.68 | -122.70 | -113.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.43M | -73.68M | -113.68M | -122.70M | -113.67M |
| EBIT | -70.61M | -82.71M | -108.81M | -121.70M | -122.61M |
| EBITDA | -60.97M | -72.61M | -99.29M | -113.02M | -114.71M |
| EPS Basic | -0.84 | -0.98 | -1.50 | -1.62 | -1.51 |
| Normalized Basic EPS | -0.47 | -0.56 | -0.75 | -0.83 | -0.85 |
| EPS Diluted | -0.85 | -0.98 | -1.50 | -1.62 | -1.51 |
| Normalized Diluted EPS | -0.47 | -0.56 | -0.75 | -0.83 | -0.85 |
| Average Basic Shares Outstanding | 300.94M | 301.30M | 302.35M | 303.40M | 299.57M |
| Average Diluted Shares Outstanding | 303.10M | 303.48M | 302.50M | 303.52M | 299.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |